Cevimeline Hydrochloride 30 mg/1 (Cevimeline Hydrochloride CAPSULE) 30 mg/1

Cevimeline Hydrochloride works by stimulating muscarinic (M3) receptors in the salivary glands. This stimulation increases the production of saliva, helping to relieve dry mouth symptoms. The drug mimics the action of acetylcholine, a natural neurotransmitter, to enhance glandular function and improve moisture levels in the mouth.

The usual dose of Cevimeline Hydrochloride is 30 mg taken three times a day. However, the exact dosage should be determined by your healthcare provider based on your specific condition and medical history. Always follow your doctor's instructions for the best results.

The safety of Cevimeline Hydrochloride during pregnancy or breastfeeding has not been established. It is important to consult with your healthcare provider to discuss the potential risks and benefits before using this medication if you are pregnant or breastfeeding.

To order Cevimeline Hydrochloride from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Cevimeline Hydrochloride is a muscarinic receptor agonist specifically designed to increase saliva production in patients with Sjögren's syndrome. Compared to other treatments like artificial saliva substitutes or pilocarpine, cevimeline has a more targeted mechanism of action and may be more effective in certain patients. However, the choice of treatment depends on individual patient needs and should be discussed with a healthcare provider.

Cevimeline Hydrochloride should be stored at room temperature, away from moisture and light. Keep the medication in its original container, tightly closed, and out of reach of children. Avoid exposing the capsules to excessive heat or humidity, as this may affect their stability and effectiveness.

Cevimeline Hydrochloride is administered orally in capsule form. The capsules should be taken with or without food, as directed by your healthcare provider. It is important to take the medication at the same times each day to maintain consistent levels of the drug in your body.

The most serious risks associated with Cevimeline Hydrochloride include severe nausea or vomiting, indigestion or stomach pain, itchy skin, light-colored stools, yellow eyes or skin, bloody or cloudy urine, pain in the lower back or side, chest pain or tightness, and irregular heartbeat. If you experience any of these symptoms, seek medical attention immediately.

Cevimeline Hydrochloride should not be used by patients with uncontrolled asthma, known hypersensitivity to cevimeline, acute iritis, or narrow-angle glaucoma. It should also be used with caution in patients with a history of cardiovascular disease, chronic bronchitis, or chronic obstructive pulmonary disease (COPD). Always consult with your healthcare provider to determine if this medication is suitable for you.